FDA Orange Book · active-ingredient family
Midazolam hydrochloride
Midazolam hydrochloride is approved as 4 brand and 36 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) · NDA 216359
4
Brand (NDA)
36
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, solution, syrup
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)RLD | RAFA LABS LTD | NDA 216359 | — | Aug 08, 2022 | |
| SEIZALAMRLD | MMT | NDA 209566 | — | Sep 14, 2018 | |
| VERSEDRLD | ROCHE | NDA 020942 | — | Oct 15, 1998 | |
| VERSEDRLD×2 | HLR | NDA 018654 | — | May 26, 1987 |
Generic (ANDA) products (36)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MIDAZOLAM HYDROCHLORIDE×2 | MICRO LABS | ANDA 217504 | AP | Aug 21, 2023 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HIKMA | ANDA 212847 | AP | Dec 11, 2020 | |
| MIDAZOLAM HYDROCHLORIDE | FRESENIUS KABI USA | ANDA 208878 | — | Mar 28, 2017 | |
| MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE×2 | FRESENIUS KABI USA | ANDA 203460 | AP | Aug 22, 2014 | |
| MIDAZOLAM HYDROCHLORIDE | GLAND PHARMA LTD | ANDA 090696 | AP | Feb 29, 2012 | |
| MIDAZOLAM HYDROCHLORIDE | GLAND PHARMA LTD | ANDA 090850 | AP | Jan 25, 2012 | |
| MIDOZALAM HYDROCHLORIDE×2 | ONESOURCE SPECIALTY | ANDA 090316 | AP | May 04, 2011 | |
| MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE×2 | ONESOURCE SPECIALTY | ANDA 090315 | AP | Nov 29, 2010 | |
| MIDAZOLAM HYDROCHLORIDE×2 | PH HEALTH | ANDA 078511 | — | Nov 10, 2008 | |
| MIDAZOLAM HYDROCHLORIDE×2 | PH HEALTH | ANDA 078141 | — | May 30, 2008 | |
| MIDAZOLAM HYDROCHLORIDE | PHARM ASSOC | ANDA 077115 | — | Sep 09, 2005 | |
| MIDAZOLAM HYDROCHLORIDE | PADAGIS US | ANDA 076379 | AA | May 02, 2005 | |
| MIDAZOLAM HYDROCHLORIDE×2 | INTL MEDICATED | ANDA 076144 | — | Jan 26, 2005 | |
| MIDAZOLAM HYDROCHLORIDE×2 | INTL MEDICATION | ANDA 076020 | — | Jul 16, 2004 | |
| MIDAZOLAM HYDROCHLORIDE | PAI HOLDINGS | ANDA 075958 | — | Sep 04, 2003 | |
| MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE×2 | HOSPIRA | ANDA 075857 | AP | Jul 22, 2002 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HOSPIRA | ANDA 075856 | — | Jun 13, 2002 | |
| MIDAZOLAM HYDROCHLORIDE | HIKMA | ANDA 075873 | AA | Apr 30, 2002 | |
| MIDAZOLAM HYDROCHLORIDE | SUN PHARM INDS LTD | ANDA 076058 | — | Mar 15, 2002 | |
| MIDAZOLAM HYDROCHLORIDE×2 | APOTHECON | ANDA 075620 | — | Nov 01, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | BAXTER HLTHCARE CORP | ANDA 075637 | — | Oct 31, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | APOTHECON | ANDA 075641 | — | Oct 19, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | EPIC PHARMA LLC | ANDA 075481 | — | Jun 30, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | RISING | ANDA 075494 | AP | Jun 30, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | IGI LABS INC | ANDA 075263 | — | Jun 26, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | BEDFORD | ANDA 075249 | — | Jun 23, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HIKMA | ANDA 075247 | AP | Jun 23, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | BEN VENUE | ANDA 075455 | — | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | FRESENIUS KABI USA | ANDA 075154 | AP | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HIKMA | ANDA 075243 | AP | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HIKMA | ANDA 075324 | AP | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HIKMA | ANDA 075421 | AP | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HOSPIRA | ANDA 075293 | AP | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HOSPIRA | ANDA 075396 | — | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE | HOSPIRA | ANDA 075484 | — | Jun 20, 2000 | |
| MIDAZOLAM HYDROCHLORIDE×2 | HOSPIRA INC | ANDA 075409 | — | Jun 20, 2000 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Midazolam hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

